The latest closing stock price for Rapt Therapeutics as of January 21, 2025 is 1.20.
An investor who bought $1,000 worth of Rapt Therapeutics stock at the IPO in 2019 would have $-906 today, roughly -1 times their original investment - a -37.62% compound annual growth rate over 5 years.
The all-time high Rapt Therapeutics stock closing price was 48.86 on January 27, 2020.
The Rapt Therapeutics 52-week high stock price is 27.35, which is 2179.2% above the current share price.
The Rapt Therapeutics 52-week low stock price is 0.79, which is 34.2% below the current share price.
The average Rapt Therapeutics stock price for the last 52 weeks is 5.32.
An investor who bought $1,000 worth of Rapt Therapeutics stock at the IPO in 2019 would have $-906 today, roughly -1 times their original investment - a -37.62% compound annual growth rate over 5 years.
The all-time high Rapt Therapeutics stock closing price was 48.86 on January 27, 2020.
The Rapt Therapeutics 52-week high stock price is 27.35, which is 2179.2% above the current share price.
The Rapt Therapeutics 52-week low stock price is 0.79, which is 34.2% below the current share price.
The average Rapt Therapeutics stock price for the last 52 weeks is 5.32.